These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5783581)

  • 1. Effect of triiodothyronine administration on serum PBI in hypothyroid patients maintained on constant doses of thyroxine.
    Farmer TA; Smitherman TC; Beschi RJ; Pittman JA
    J Clin Endocrinol Metab; 1969 Jun; 29(6):781-5. PubMed ID: 5783581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of l-triiodothyronine and d-thyroxine on the binding of thyroid hormones by serum proteins and on blood lipids in hypothyroidism].
    Felt V; Strasek J
    Vnitr Lek; 1968 Dec; 14(12):1150-3. PubMed ID: 4178547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Total hormonal iodine in serum as a parameter of thyroid function. Comparison with the values of PBI in healthy children, in children with hypothyroidism during therapy and in children with tall stature].
    Stolecke H; ter Huerne C
    Z Kinderheilkd; 1971; 111(3):175-83. PubMed ID: 4110195
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiologic combinations of synthetic thyroid hormones in myxedema.
    Wool MS; Selenkow HA
    Clin Pharmacol Ther; 1965; 6(6):710-5. PubMed ID: 4158675
    [No Abstract]   [Full Text] [Related]  

  • 5. THYROID THERAPY OF MYXEDEMA: A COMPARISON OF VARIOUS AGENTS WITH A NOTE ON THE COMPOSITION OF THYROID SECRETION IN MAN.
    LAVIETES PH; EPSTEIN FH
    Ann Intern Med; 1964 Jan; 60():79-87. PubMed ID: 14104859
    [No Abstract]   [Full Text] [Related]  

  • 6. The binding of 1-triiodothyronine to plasma proteins. Cross-linked high molecular polysaccharide sorption of 1-triiodothyronine as a method of evaluating a clinical T3-test and to characterize 1-triiodothyronine-protein binding.
    Hansen HH
    Dan Med Bull; 1969 Apr; 16():Suppl 2:1-73. PubMed ID: 4989924
    [No Abstract]   [Full Text] [Related]  

  • 7. [The value of PBI-test in the treatment of myxedema and goiter].
    Christensen LK
    Nord Med; 1968 Apr; 79(15):490. PubMed ID: 4173087
    [No Abstract]   [Full Text] [Related]  

  • 8. Myxedema coma precipitated by diabetic ketoacidosis after total thyroidectomy: a case report.
    Kim JJ; Kim EY
    J Med Case Rep; 2019 Mar; 13(1):50. PubMed ID: 30827279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxedema. Recognition and treatment.
    Gilliland PF
    Postgrad Med; 1975 Jun; 57(7):61-5. PubMed ID: 48244
    [No Abstract]   [Full Text] [Related]  

  • 10. HYPOTHYROIDISM AND MYXEDEMA.
    RUNYAN JW
    J Tenn Med Assoc; 1963 Oct; 56():391-4. PubMed ID: 14076541
    [No Abstract]   [Full Text] [Related]  

  • 11. Total and free human serum thyroxine in normal and abnormal thyroid states.
    Arango G; Mayberry WE; Hockert TJ; Elveback LR
    Mayo Clin Proc; 1968 Jul; 43(7):503-16. PubMed ID: 4179667
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between the thyroxine-binding capacity of blood proteins and the serum organic iodine level.
    Reviczky AL; Szántó L
    Acta Physiol Acad Sci Hung; 1967; 32(4):337-48. PubMed ID: 4174606
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum thyrotrophin in myxedema and in asymptomatic atrophic thyroiditis.
    Bonnyns M; Bastenie PA
    J Clin Endocrinol Metab; 1967 Jun; 27(6):849-54. PubMed ID: 6026364
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpretation of serum tri-iodothyronine levels measured by the sterling technic.
    Wahner HW; Gorman CA
    N Engl J Med; 1971 Feb; 284(5):225-30. PubMed ID: 4992676
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine.
    Ridgway EC; McCammon JA; Benotti J; Maloof F
    Ann Intern Med; 1972 Oct; 77(4):549-55. PubMed ID: 4642735
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for the treatment of myxedema.
    Green WL
    Med Clin North Am; 1968 Mar; 52(2):431-50. PubMed ID: 4872212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evolution of iodine uptake, PBI-131, PBI-127 and clinical symptoms following administration of triiodothyronine to subjects with hyperthyroidism caused by diffuse thyroid hyperplasia. Role of the lymphatic system and LATS in the effect of Graves disease stimulation].
    Mahaux JE; Chamla-Soumenkof J; Nagel M; Levin S
    Ann Endocrinol (Paris); 1968; 29(4):483-95. PubMed ID: 5756676
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in basal metabolism, serumprotein-bound iodine, and cholesterol during treatment of hypothyroidism with oral thyroid and L-thyroxine sodium.
    ROBERTSON JD; KIRKPATRICK HF
    Br Med J; 1952 Mar; 1(4759):624-8. PubMed ID: 14905006
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothyroidism: mimicker of common complaints.
    Tews MC; Shah SM; Gossain VV
    Emerg Med Clin North Am; 2005 Aug; 23(3):649-67, vii. PubMed ID: 15982539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long acting thyroid stimulator (LATS) and iodo-amino acids in localized pretibial myxeodema.
    Samuelsson SM; Werner I
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):409-16. PubMed ID: 5754979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.